Ravelcare IPO subscribed 81.55x on Day 2

Ravelcare IPO subscription started on Monday, 1st December, and the IPO will close on December 3, 2025, as per the schedule. The price band is set at ₹123 to ₹130 per share with a face value of ₹10.

Table of Contents

Ravelcare IPO Subscription Status 

Ravelcare IPO subscribed over 81.55x on its second day till 5.00 PM on 2nd December 2025. 

  • Ravelcare IPO subscription QIB investors’ portion was 6.86 times, while NII subscribers subscribed 148.16 times, and RII investors subscribed 95.47  times. 
  • The company has received bids for 10,07,14,000 shares against 12,35,000 on offer for the second-day subscription. 
  • Ravelcare IPO subscribed over 81.55x on its day 2. 
  • Ravelcare IPO subscribed over 15.50x on its day 1.  

About Ravelcare Company 

Ravelcare Ltd. was founded in November 2018 and is one of the growing beauty and personal care brands that is involved in providing a wide range of haircare, skincare, bodycare, and scalp-care products. Ravelcare sells its products through its own website and via other E-commerce websites like Amazon, Flipkart, Myntra, and Blinkit too. Not just domestically, but the company also expanded its business internationally to countries like the UAE, Australia, Canada, Germany, the USA, and Saudi Arabia.

The company’s main aim is to develop high-quality products that will meet the requirements of each of its customers. Moreover, the company handles its own logistics and warehousing in order to provide smooth and on-time delivery. Ravelcare is also planning to build a manufacturing facility with a capacity of 1,050 TPA in Mauje-Peth, Amravati, Maharashtra.

Ravelcare IPO GMP:  

Ravelcare IPO GMP was ₹52 as of Tuesday, 2 December 2025. That indicates the IPO is trading at ₹182 with a ₹52 premium in the grey market against the issue price of ₹130.  

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *